Curative Biotechnology, Inc.
CUBT
$0.0099
$0.000.00%
OTC PK
| 03/31/2025 | 03/31/2024 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -481.60K | -1.11M | -1.29M | -1.40M | -935.90K |
| Total Depreciation and Amortization | 21.90K | 26.40K | 2.00K | 2.00K | -4.30K |
| Total Amortization of Deferred Charges | -- | 116.40K | 250.00K | 83.30K | -46.30K |
| Total Other Non-Cash Items | 21.40K | 327.70K | 77.40K | 231.90K | -19.60K |
| Change in Net Operating Assets | 252.90K | 375.00K | 647.40K | -106.70K | 426.40K |
| Cash from Operations | -185.30K | -261.20K | -310.70K | -1.19M | -579.80K |
| Capital Expenditure | -- | -- | -- | -- | -6.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -15.00K | -4.40K | -36.30K | 0.00 |
| Cash from Investing | -- | -15.00K | -4.40K | -36.30K | -6.80K |
| Total Debt Issued | -- | -- | 200.00K | 956.70K | 70.00K |
| Total Debt Repaid | -- | -- | -26.00K | -26.00K | 0.00 |
| Issuance of Common Stock | 275.50K | 115.60K | -- | -- | 548.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 108.50K | 252.80K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -30.00K | -42.30K | -68.70K | -93.00K |
| Cash from Financing | 384.00K | 338.40K | 131.70K | 861.90K | 525.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 198.70K | 62.20K | -183.40K | -360.00K | -61.60K |